Partner Content Partner Content Juergen Knoebel from Roche speaks at the High Potent Medicin... Insights on HPAPI manufacturing
Events Partner Content The High Potent Medicines Conference The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
